Cargando…
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
Vascular damage is followed by vascular endothelial growth factor (VEGF) expression at high levels, which is an important mechanism forradiation brain necrosis development. Bevacizumab alleviates brain edema symptoms caused by radiation brain necrosis through inhibiting VEGF and acting on vascular t...
Autores principales: | Zhuang, Hongqing, Shi, Siyu, Yuan, Zhiyong, Chang, Joe Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367784/ https://www.ncbi.nlm.nih.gov/pubmed/30732625 http://dx.doi.org/10.1186/s12943-019-0950-1 |
Ejemplares similares
-
Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report
por: Zhuang, Hongqing, et al.
Publicado: (2016) -
Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016) -
A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis
por: Zhuang, Hongqing, et al.
Publicado: (2016) -
Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study
por: Zhuang, Hongqing, et al.
Publicado: (2019) -
Analysis of risk and predictors of brain radiation necrosis after radiosurgery
por: Zhuang, Hongqing, et al.
Publicado: (2015)